Skip to main content
NewslettersWatchlist

Organon & Co.(OGN-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low18.33
Day High18.68
Open:18.43
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Newswire.ca
On International Women's Day, Organon Canada is encouraging businesses to Invest in HER and help address gender inequities through women's health
Motley Fool
Is This Healthcare Stock's 10% Yield a Steal of a Deal or Too Good to Be True?
Baystreet
Is This Healthcare Stock’s 8.7% Dividend Yield Safe?
Newswire.ca
Organon Canada Announces Availability of a High-Concentration, Citrate-Free Formulation of HADLIMA®, a Biosimilar to HUMIRA*
MarketBeat
Lululemon Athletica Races to New High with S&P 500 Entry
Barchart
Stocks Rally on Slightly Reduced Geopolitical Risks in the Middle East
PR Newswire
Lululemon Athletica & Hubbell Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
Motley Fool
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
Barchart
Stocks Close Lower on Bank Worries
Barchart
Stocks Fall on Regional Bank Jitters
Motley Fool
Need an Extra $4,000 in Dividends Each Year? Invest $68,000 in These 3 Stocks.
Motley Fool
Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks
The Globe and Mail
Organon: Top 25 Undervalued S&P 500 Composite Index Stocks (OGN)
Barchart
Stocks Finish Higher as Negotiators Inch Toward a Debt-Ceiling Agreement
Newswire.ca
ORGANON CANADA TO SUPPORT LE CHAÎNON BY FUNDING THE INITIAL CONSTRUCTION PHASE OF ITS MEDICAL CLINIC
Newswire.ca
Media Advisory - Organon Canada to announce funding in support of women's shelter Le Chaînon, as well as the unveiling of a space at Organon Canada's offices in honour of Ms. Maisonneuve, founder of Le Chaînon
The Globe and Mail
Organon: Top 25 Undervalued Dow Jones Composite Index Stocks (OGN)
Barchart
Stocks Tumble as Liquidity Concerns Rout Regional Bank Stocks
Barchart
Stocks Undercut as Regional Bank Stocks Plunge
Business Wire
Organon Reports Results for the First Quarter Ended March 31, 2023
Business Wire
Organon To Report First Quarter and Host Conference Call on May 4, 2023
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organon & Co. - OGN
Business Wire
Organon Launches “Her Plan is Her Power,” a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist
Newswire.ca
Organon Canada receives the Women in Governance (WiG) Parity Certification SME, further demonstrating its commitment to gender parity in the workplace
Newswire.ca
Ahead of International Women's Day, Organon Canada Spotlights the Importance of Supporting Women's Equity While Highlighting the Cost of Not Investing in Their Health
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organon & Co. - OGN
Motley Fool
Why Shares of Organon Fell 15% Thursday
Barchart
Stocks Slump as Fed Officials Mention Bigger Rate Hikes
Barchart
Strength in U.S. Producer Prices and Hawkish Fed Speak Weighs on Stocks
Business Wire
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2022
PR Newswire
Ahead of International Women's Day, Organon Calls for Recognition of the Impacts of Underinvesting in Women's Health
Business Wire
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023

Profile

Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.